TY - JOUR
T1 - Structural and mutational analysis of the xeroderma pigmentosum group D (XPD) gene
AU - Frederick, Gregory D.
AU - Amirkhan, Robin H.
AU - Schultz, Roger A.
AU - Friedberg, Errol C.
N1 - Funding Information:
We thank R.Walter at Southwest Texas State University for providing information concerning the Xiphophorus ERCC2 protein prior to publication. We also thank E.G.Jung for providing the XP-D primary cell line XP67MA, E.Radany and L.Bardwell for meir involvement in the construction of plasmid pVCSRa-£7?CC2 and our laboratory colleagues for discussion and criticisms. These studies were supported by research grant CA-44247 from the USPHS (ECF).
PY - 1994/10
Y1 - 1994/10
N2 - Individuals affected by the autosomal recessive disease xeroderma pigmentosum (XP) are acutely sensitive to sunlight and predisposed to skin cancer on exposed areas. Cells cultured from XP patients are both UV sensitive and defective in the nucleotide excision repair of damaged DNA. These cellular phenotypes are amenable to experimental strategies employing complementation, an approach previously used to demonstrate the correction of XP-D phenotypes following the introduction of the XPD (ERCC2) gene. In the present study, we have characterized the genomic organization of the XPD (ERCC2) gene and found it to be comprised of 23 exons. These data were helpful in evaluating the functional integrity of alleles in two XP-D cell lines. In cell line GM436 a C→G transversion was found at nucleotide position 1411 in the XPD (ERCC2) cDNA, a change expected to result in a Leu461Val substitution. Cell line XP67MA carries a C→T transition in genomic DNA at nucleotide position 2176 in exon 22, introducing the termination codon TAG at amino acid 726. The latter would be expected to produce a protein truncated by 34 amino acids. Although expression of the normal XPD cDNA could be shown to correct the UV sensitivity phenotype in XP-D cells, cDNA constructs bearing either of the two mutations failed to yield complementation. These results confirm the role of ERCC2 in XP-D and illustrate the power of utilizing cellular phenotypes to evaluate the significance of single nucleotide substitutions.
AB - Individuals affected by the autosomal recessive disease xeroderma pigmentosum (XP) are acutely sensitive to sunlight and predisposed to skin cancer on exposed areas. Cells cultured from XP patients are both UV sensitive and defective in the nucleotide excision repair of damaged DNA. These cellular phenotypes are amenable to experimental strategies employing complementation, an approach previously used to demonstrate the correction of XP-D phenotypes following the introduction of the XPD (ERCC2) gene. In the present study, we have characterized the genomic organization of the XPD (ERCC2) gene and found it to be comprised of 23 exons. These data were helpful in evaluating the functional integrity of alleles in two XP-D cell lines. In cell line GM436 a C→G transversion was found at nucleotide position 1411 in the XPD (ERCC2) cDNA, a change expected to result in a Leu461Val substitution. Cell line XP67MA carries a C→T transition in genomic DNA at nucleotide position 2176 in exon 22, introducing the termination codon TAG at amino acid 726. The latter would be expected to produce a protein truncated by 34 amino acids. Although expression of the normal XPD cDNA could be shown to correct the UV sensitivity phenotype in XP-D cells, cDNA constructs bearing either of the two mutations failed to yield complementation. These results confirm the role of ERCC2 in XP-D and illustrate the power of utilizing cellular phenotypes to evaluate the significance of single nucleotide substitutions.
UR - http://www.scopus.com/inward/record.url?scp=0027941546&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027941546&partnerID=8YFLogxK
U2 - 10.1093/hmg/3.10.1783
DO - 10.1093/hmg/3.10.1783
M3 - Article
C2 - 7849702
AN - SCOPUS:0027941546
SN - 0964-6906
VL - 3
SP - 1783
EP - 1788
JO - Human Molecular Genetics
JF - Human Molecular Genetics
IS - 10
ER -